New discovery rarely runs smooth: an update on progranulin/TNFR interactions

Protein and Cell

Volumn 6, Issue 11, 2015, Pages 792-803

  Wang, Betty C ^a   Liu, Helen ^b   Talwar, Ankoor ^c   Jian, Jinlong ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNION COLLEGE   (United States)

Author keywords

Atsttrin; DR3; progranulin; TL1A; TNF ; TNFR

Indexed keywords

CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MOLECULAR SCAFFOLD; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRANULIN; PROTEIN KINASE B; SORTILIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; WNT5A PROTEIN; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

APOPTOSIS; AUTOIMMUNE DISEASE; CATABOLISM; CLINICAL RESEARCH; COLITIS; ENDOPLASMIC RETICULUM STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; FRACTURE HEALING; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; IMMUNOPRECIPITATION; INFLAMMATION; INSULIN RESISTANCE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945444803     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-015-0213-x     Document Type: Review

References (81)

1. Aggarwal BB (2014) Editorial: balancing tumor necrosis factor receptor I and tumor necrosis factor receptor II jointly for joint inflammation. Arthritis Rheumatol 66:2657–2660
2. Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW (2007) Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 4:7
3. Almeida S, Zhou L, Gao FB (2011) Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins. PloS One 6:e26454
4. Alquezar C, Encarnación A, Moreno F, Munain A, Martín-Requero Á (2015) Progranulin deficiency induces over activation of Wnt5a expression via TNFα/NF-κB pathway in peripheral cells from FTLD-linked GRN mutation carriers. J Psychiatry Neurosci (in press)
5. Baker CA, Manuelidis L (2003) Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 100:675–679
6. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916–919
7. Bateman A, Bennett HP (2009) The granulin gene family: from cancer to dementia. BioEssays 31:1245–1254
8. Bluml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E et al (2010) Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis Rheum 62:1608–1619
9. Bluml S, Scheinecker C, Smolen JS, Redlich K (2012) Targeting TNF receptors in rheumatoid arthritis. Int Immunol 24:275–281
10. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K et al (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79–88
11. Cavalli G, Dinarello CA (2015) Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). doi:10.1093/rheumatology/kev269
12. Chen X, Chang J, Deng Q, Xu J, Nguyen TA, Martens LH, Cenik B, Taylor G, Hudson KF, Chung J et al (2013) Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells. J Neurosci 33:9202–9213
13. Chinnaiyan AM, O’Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990–992
14. Conti P (1991) Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra). Ann Med Int 142:521–525
15. Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271–285
16. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920–924
17. Diaz-Cueto L, Arechavaleta-Velasco F, Diaz-Arizaga A, Dominguez-Lopez P, Robles-Flores M (2012) PKC signaling is involved in the regulation of progranulin (acrogranin/PC-cell-derived growth factor/granulin-epithelin precursor) protein expression in human ovarian cancer cell lines. Int J Gynecol Cancer 22:945–950
18. Egashira Y, Suzuki Y, Azuma Y, Takagi T, Mishiro K, Sugitani S, Tsuruma K, Shimazawa M, Yoshimura S, Kashimata M et al (2013) The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation 10:105
19. Faustman D, Davis M (2010) TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev 9:482–493
20. Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, Horvat D, Galindo C, Huang L, McMillin M, Cooper B et al (2012) Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 61:268–277
21. Grunke M, Schulze-Koops H (2006) Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis 65:555–556
22. Guo Z, Li Q, Han Y, Liang Y, Xu Z, Ren T (2012) Prevention of LPS-induced acute lung injury in mice by progranulin. Mediat Inflammation 2012:10
23. He Z, Ong CH, Halper J, Bateman A (2003) Progranulin is a mediator of the wound response. Nat Med 9:225–229
24. Huang K, Chen A, Zhang X, Song Z, Xu H, Cao J, Yin Y (2015) Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation. Immunology 145:279–287
25. Hwang HJ, Jung TW, Hong HC, Choi HY, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH et al (2013) Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-kappaB pathways. PloS One 8:e76679
26. Jian J, Konopka J, Liu C (2013a) Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol 93:199–208
27. Jian J, Zhao S, Tian Q, Gonzalez-Gugel E, Mundra JJ, Uddin SM, Liu B, Richbourgh B, Brunetti R, Liu CJ (2013b) Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Lett 587:3428–3436
28. Kawase R, Ohama T, Matsuyama A, Matsuwaki T, Okada T, Yamashita T, Yuasa-Kawase M, Nakaoka H, Nakatani K, Inagaki M et al (2013) Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice. Cardiovasc Res 100:125–133
29. Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A, Belaaouaj A, Ring J, Ollert M, Fassler R et al (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Investig 118:2438–2447
30. Kimmerling KA, Furman BD, Mangiapani DS, Moverman MA, Sinclair SM, Huebner JL, Chilkoti A, Kraus VB, Setton LA, Guilak F et al (2015) Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritis. Eur Cells Mater 29:124–139; discussion 139–140
31. Klein DE, Nappi VM, Reeves GT, Shvartsman SY, Lemmon MA (2004) Argos inhibits epidermal growth factor receptor signalling by ligand sequestration. Nature 430:1040–1044
32. Klein DE, Stayrook SE, Shi F, Narayan K, Lemmon MA (2008) Structural basis for EGFR ligand sequestration by Argos. Nature 453:1271–1275
33. Li M, Liu Y, Xia F, Wu Z, Deng L, Jiang R, Guo FJ (2014) Progranulin is required for proper ER stress response and inhibits ER stress-mediated apoptosis through TNFR2. Cell Signal 26:1539–1548
34. Li H, Zhou B, Liu J, Li F, Li Y, Kang X, Sun H, Wu S (2015) Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2alpha-dependent manner. Cell Cycle 14:1893–1907
35. Liu CJ (2011) Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Lett 585:3675–3680
36. Liu CJ, Bosch X (2012) Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 133:124–132
37. Liu C, Li XX, Gao W, Liu W, Liu DS (2014) Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity. PloS One 9:e92743
38. Liu J, Li H, Zhou B, Xu L, Kang X, Yang W, Wu S, Sun H (2015) PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance. Mol Endocrinol 29:528–541
39. Lopez de Munain A, Alzualde A, Gorostidi A, Otaegui D, Ruiz-Martinez J, Indakoetxea B, Ferrer I, Perez-Tur J, Saenz A, Bergareche A et al (2008) Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol Psychiatry 63:946–952
40. Ma CH, Lv Q, Yu YX, Zhang Y, Kong D, Niu KR, Yi CQ (2015) Protective effects of tumor necrosis factor-alpha blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et al], 0
41. Maksymowych WP, Russell AS, Chiu P, Yan A, Jones N, Clare T, Lambert RG (2012) Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 14:R206
42. Malaspina A, Kaushik N, de Belleroche J (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77:132–145
43. Maynard JA, Lindquist NC, Sutherland JN, Lesuffleur A, Warrington AE, Rodriguez M, Oh SH (2009) Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J 4:1542–1558
44. McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO (2014) Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis. Arthritis Rheumatol 66:2728–2738
45. Myszka DG (1997) Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr Opin Biotechnol 8:50–57
46. Olson SA, Furman BD, Kraus VB, Huebner JL, Guilak F (2015) Therapeutic opportunities to prevent post-traumatic arthritis: Lessons from the natural history of arthritis after articular fracture. J Orthop Res: Off Publ Orthop Res Soc 33:1266–1277
47. Palfree RG, Bennett HP, Bateman A (2015) The evolution of the secreted regulatory protein progranulin. PloS One 10:e0133749
48. Reis CR, van Assen AH, Quax WJ, Cool RH (2011) Unraveling the binding mechanism of trivalent tumor necrosis factor ligands and their receptors. Mol Cell Proteom: MCP 10(M110):002808
49. Scott LJ (2014) Etanercept: a review of its use in autoimmune inflammatory diseases. Drugs 74:1379–1410
50. Serrero G (2003) Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 308:409–413
51. Sfikakis PP, Tsokos GC (2011) Towards the next generation of anti-TNF drugs. Clin Immunol 141:231–235
52. Tadagavadi RK, Reeves WB (2015) NODding off in acute kidney injury with progranulin? Kidney Int 87:873–875
53. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332:478–484
54. Thurner L, Preuss KD, Fadle N, Regitz E, Klemm P, Zaks M, Kemele M, Hasenfus A, Csernok E, Gross WL et al (2013a) Progranulin antibodies in autoimmune diseases. J Autoimmun 42:29–38
55. Thurner L, Zaks M, Preuss KD, Fadle N, Regitz E, Ong MF, Pfreundschuh M, Assmann G (2013b) Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Res Ther 15:R211
56. Thurner L, Stoger E, Fadle N, Klemm P, Regitz E, Kemele M, Bette B, Held G, Dauer M, Lammert F et al (2014) Proinflammatory progranulin antibodies in inflammatory bowel diseases. Dig Dis Sci 59:1733–1742
57. Thurner L, Fadle N, Regitz E, Kemele M, Klemm P, Zaks M, Stoger E, Bette B, Carbon G, Zimmer V et al (2015) The molecular basis for development of proinflammatory autoantibodies to progranulin. J Autoimmun 61:17–28
58. Tian QY, Zhao YP, Liu CJ (2012) Modified yeast-two-hybrid system to identify proteins interacting with the growth factor progranulin. J Vis Exp. doi:10.3791/3562
59. Tian Q, Zhao S, Liu C (2014a) A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF/TNFR interactions. Methods Mol Biol 1155:163–172
60. Tian Q, Zhao Y, Mundra JJ, Gonzalez-Gugel E, Jian J, Uddin SM, Liu C (2014b) Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity. Front Biosci (Landmark Ed) 19:1176–1185
61. Urech DM, Feige U, Ewert S, Schlosser V, Ottiger M, Polzer K, Schett G, Lichtlen P (2010) Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic use. Ann Rheum Dis 69:443–449
62. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181:37–41
63. van der Merwe PA, Brown MH, Davis SJ, Barclay AN (1993) Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48. EMBO J 12:4945–4954
64. Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D (2012) Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 71:891–898
65. Vercellino M, Grifoni S, Romagnolo A, Masera S, Mattioda A, Trebini C, Chiavazza C, Caligiana L, Capello E, Mancardi GL et al (2011) Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis. Mult Scler 17:1194–1201
66. Vezina A, Vaillancourt-Jean E, Albarao S, Annabi B (2014) Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-alpha and requires NF-kappaB signaling. Cancer Lett 345:100–105
67. Wang C, Luo X, Li P, Chen X, Zhou H, Zhang T (2015a) An improved method of GST-pull down based on fluorescence detection and its application to the analysis of the interaction between atsttrin and TNFR2. J Tianjin Univ Sci Technol 30:34–40
68. Wang Q, Xia Q, Wu Y, Zhang X, Wen F, Chen X, Zhang S, Heng BC, He Y, Ouyang HW (2015b) 3D-printed atsttrin-incorporated alginate/hydroxyapatite scaffold promotes bone defect regeneration with tnf/tnfr signaling involvement. Adv Healthc Mater 4:1701–1708
69. Wei F, Zhang Y, Jian J, Mundra JJ, Tian Q, Lin J, Lafaille JJ, Tang W, Zhao W, Yu X et al (2014a) PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. Sci Rep 4:7023
70. Wei F, Zhang Y, Zhao W, Yu X, Liu CJ (2014b) Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PloS One 9:e112110
71. Wu H, Siegel RM (2011) Medicine. Progranulin resolves inflammation. Science 332:427–428
72. Xia Q, Zhu S, Wu Y, Wang J, Cai Y, Chen P, Li J, Heng BC, Ouyang HW, Lu P (2015) Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development. Stem Cells Transl Med 4:523–531
73. Yamamoto Y, Takemura M, Serrero G, Hayashi J, Yue B, Tsuboi A, Kubo H, Mitsuhashi T, Mannami K, Sato M et al (2014) Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis. Inflammation 37:1806–1813
74. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, Beal MF et al (2010) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207:117–128
75. Zhang Q, Lv H, Chen A, Liu F, Wu X (2012) Efficacy of infliximab in a rabbit model of osteoarthritis. Connect Tissue Res 53:355–358
76. Zhao YP, Tian QY, Frenkel S, Liu CJ (2013a) The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling. Biomaterials 34:6412–6421
77. Zhao YP, Tian QY, Liu CJ (2013b) Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice. FEBS Lett 587:1805–1810
78. Zhao YP, Liu B, Tian QY, Wei JL, Richbourgh B, Liu CJ (2014) Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling. Ann Rheum Dis. doi:10.1136/annrheumdis-2014-205779
79. Zheng Y, Brady OA, Meng PS, Mao Y, Hu F (2011) C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking. PloS One 6:e21023
80. Zhou M, Tang W, Fu Y, Xu X, Wang Z, Lu Y, Liu F, Yang X, Wei X, Zhang Y et al (2015) Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int 87:918–929
81. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111:867–878